Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value: $132M (100.0% shares, 0.0% debt)

Holdings (17)

— Biohaven Pharmactl Hldg Co L 29.3%

Value $38.59M Shares 749,815 Est. Cost $25.00 Unrealized —

— Corbus Pharmaceuticals HLDGS 26.3%

Value $34.65M Shares 4,985,870 Est. Cost $4.98 Unrealized —

— Abeona Therapeutics Inc 13.2%

Value $17.37M Shares 2,359,767 Est. Cost $4.97 Unrealized —

KRYS Krystal Biotech Inc 5.3%

Value $6.909M Shares 209,986 Est. Cost $10.08 Unrealized +133.8%

— Blackstone Group LP 4.1%

Value $5.35M Shares 153,000 Est. Cost $34.97 Unrealized —

MO Altria Group Inc 3.9%

Value $5.169M Shares 90,000 Est. Cost $29.72 Unrealized 0.0%

— DowDupont Inc 3.6%

Value $4.798M Shares 90,000 Est. Cost $53.31 Unrealized —

ALDX Aldeyra Therapeutics Inc 3.3%

Value $4.371M Shares 484,096 Est. Cost $8.65 Unrealized -1.8%

KBA Kraneshares TR 2.3%

Value $3.061M Shares 96,000 Est. Cost $31.89 Unrealized —

— Electrocore Inc 2.1%

Value $2.778M Shares 396,825 Est. Cost $16.51 Unrealized —

AVXL Anavex Life Sciences Corp 1.7%

Value $2.209M Shares 724,205 Est. Cost $3.56 Unrealized -33.0%

ENTX Entera Bio Ltd 1.6%

Value $2.057M Shares 475,540 Est. Cost $6.29 Unrealized -35.5%

— Galmed Pharmaceuticals Ltd 1.3%

Value $1.684M Shares 206,099 Est. Cost $11.90 Unrealized —

— Eiger Biopharmaceuticals Inc 0.8%

Value $1.052M Shares 75,238 Est. Cost $9.85 Unrealized —

— Soligenix Inc. 0.6%

Value $767K Shares 837,800 Est. Cost $2.11 Unrealized —

— Molecular Templates 0.5%

Value $662K Shares 113,905 Est. Cost $4.04 Unrealized —

— Lipocine Inc New 0.1%

Value $116K Shares 50,000 Est. Cost $1.30 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmactl Hldg Co L	749,815	$38.59M	29.3%	$25.00	—	COM	G11196105
—	Corbus Pharmaceuticals HLDGS	4,985,870	$34.65M	26.3%	$4.98	—	COM	21833P103
—	Abeona Therapeutics Inc	2,359,767	$17.37M	13.2%	$4.97	—	COM	00289Y107
KRYS	Krystal Biotech Inc	209,986	$6.909M	5.3%	$10.08	+133.8%	COM	501147102
—	Blackstone Group LP	153,000	$5.35M	4.1%	$34.97	—	COM UNIT LTD	09253U108
MO	Altria Group Inc	90,000	$5.169M	3.9%	$29.72	0.0%	COM	02209S103
—	DowDupont Inc	90,000	$4.798M	3.6%	$53.31	—	COM	26078J100
ALDX	Aldeyra Therapeutics Inc	484,096	$4.371M	3.3%	$8.65	-1.8%	COM	01438T106
KBA	Kraneshares TR	96,000	$3.061M	2.3%	$31.89	—	BOSERA MSCI CH	500767405
—	Electrocore Inc	396,825	$2.778M	2.1%	$16.51	—	COM	28531P103
AVXL	Anavex Life Sciences Corp	724,205	$2.209M	1.7%	$3.56	-33.0%	COM NEW	032797300
ENTX	Entera Bio Ltd	475,540	$2.057M	1.6%	$6.29	-35.5%	SHS	M40527109
—	Galmed Pharmaceuticals Ltd	206,099	$1.684M	1.3%	$11.90	—	SHS	M47238106
—	Eiger Biopharmaceuticals Inc	75,238	$1.052M	0.8%	$9.85	—	COM	28249U105
—	Soligenix Inc.	837,800	$767K	0.6%	$2.11	—	COM	834223307
—	Molecular Templates	113,905	$662K	0.5%	$4.04	—	COM	608550109
—	Lipocine Inc New	50,000	$116K	0.1%	$1.30	—	COM	53630X104